MedTrace Logo

The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer

NCT01896713 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2013-07-11

No results posted yet for this study

Summary

MultiSpectral 3 Tesla MRI (MS3TMRI) can increase the yield of Trans Rectal Ultrasound Biopsy (TRUSBx) to improve identification of patients on active surveillance requiring treatment.

Conditions

Interventions

OTHER

MS3TMRI

Multispectral 3 Tesla MRI imaging with contrast followed by biopsy

Sponsors & Collaborators

  • Philips Healthcare

    collaborator INDUSTRY

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Masoom Haider, MD · Sunnybrook Health Sciences Centre, University of Toronto

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01896713 on ClinicalTrials.gov